MedTrace Logo

Intravenous Tranexamic Acid During Rhytidectomy

NCT03970213 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2019-05-31

No results posted yet for this study

Summary

This is a prospective, randomized, double-blind study investigating whether intravenous tranexamic acid has any effect on rhytidectomy surgery, or the subsequent postoperative sequelae. Intraoperative bleeding and postoperative ecchymosis and edema are subjectively rated and complications are noted.

Conditions

  • Bleeding
  • Bruising Face
  • Swelling Lips & Face

Interventions

DRUG

Tranexamic Acid 100Mg/Ml Inj Vil 10Ml

IV TXA given during surgery

DRUG

Normal Saline 0.9% Infusion Solution Bag

IV saline given during surgery

Sponsors & Collaborators

  • Glasgold Group Plastic Surgery

    lead OTHER

Principal Investigators

  • Mark J Glasgold, MD · Glasgold Group Plastic Surgery

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-05-30
Primary Completion
2019-08-30
Completion
2019-08-30
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03970213 on ClinicalTrials.gov